Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is a publicly traded Healthcare sector company. As of October 29, 2026, MRVI trades at $8.09 with a market cap of $1.23B and a P/E ratio of -14.10. MRVI moved +2.97% today. Year to date, MRVI is +150.00%; over the trailing twelve months it is +163.16%. Its 52-week range spans $1.67 to $9.42. Analyst consensus is buy with an average price target of $7.88. Rallies surfaces MRVI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MRVI moved +2.97% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $8.09 |
| Market Cap | $1.23B |
| P/E Ratio | -14.10 |
| EPS | $-0.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.42 |
| 52-Week Low | $1.67 |
| Volume | 2.33M |
| Avg Volume | 0 |
| Revenue (TTM) | $208.78M |
| Net Income | $-136.08M |
| Gross Margin | 34.89% |
6 analysts cover MRVI: 0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.88.